Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Acer Medical Inc. is a company dedicated to the healthcare industry, providing advanced solutions that incorporate artificial intelligence, clinical data analysis, and specialized software. Their product lineup features VeriSee DR, an AI-powered diagnostic tool for detecting diabetic retinopathy; VeriSee AMD, an AI-enabled screening application focused on identifying age-related macular degeneration; and VeriOsteo OP, an AI-assisted screening software used to detect anomalies in bone mineral density. The company was established in 2018 and is headquartered in New Taipei City, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of 6857.TWO is 76.6 and suggests 15.8% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation